PMC:7696151 / 4518-5131
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 138 | 463-471 | Species | denotes | patients | Tax:9606 |
| 139 | 9-11 | Chemical | denotes | CQ | MESH:D002738 |
| 140 | 16-19 | Chemical | denotes | HCQ | MESH:D006886 |
| 141 | 40-49 | Chemical | denotes | phosphate | MESH:D010710 |
| 142 | 54-62 | Chemical | denotes | sulphate | MESH:D013431 |
| 143 | 164-167 | Chemical | denotes | HCQ | MESH:D006886 |
| 144 | 197-199 | Chemical | denotes | CQ | MESH:D002738 |
| 145 | 215-223 | Disease | denotes | toxicity | MESH:D064420 |
| 146 | 255-261 | Disease | denotes | nausea | MESH:D009325 |
| 147 | 263-277 | Disease | denotes | stomach cramps | MESH:D009120 |
| 148 | 312-321 | Disease | denotes | diarrhoea | MESH:D003967 |
| 149 | 408-419 | Disease | denotes | retinopathy | MESH:D012164 |
| 150 | 455-462 | Disease | denotes | malaria | MESH:D008288 |
| 151 | 487-508 | Disease | denotes | inflammatory diseases | MESH:D007249 |
| 152 | 514-534 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 153 | 536-552 | Disease | denotes | Sjögren syndrome | MESH:D012859 |
| 154 | 554-569 | Disease | denotes | dermatomyositis | MESH:D003882 |
| 155 | 575-603 | Disease | denotes | systemic lupus erythematosus | MESH:D008180 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T4 | 255-261 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
| T5 | 312-321 | Phenotype | denotes | diarrhoea | http://purl.obolibrary.org/obo/HP_0002014 |
| T6 | 408-419 | Phenotype | denotes | retinopathy | http://purl.obolibrary.org/obo/HP_0000488 |
| T7 | 514-534 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
| T8 | 575-603 | Phenotype | denotes | systemic lupus erythematosus | http://purl.obolibrary.org/obo/HP_0002725 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T36 | 0-142 | Sentence | denotes | Usually, CQ and HCQ are administered as phosphate and sulphate salts, respectively, and both drugs are absorbed in the upper intestinal tract. |
| T37 | 143-229 | Sentence | denotes | However, clinically, HCQ is more frequently used than CQ for its lesser toxicity [11]. |
| T38 | 230-420 | Sentence | denotes | Both molecules give mild nausea, stomach cramps, gastrointestinal upset, and mild diarrhoea as adverse effects and long-term usage determines loss of retinal function and severe retinopathy. |
| T39 | 421-613 | Sentence | denotes | These drugs are used, to date, in malaria patients and in several inflammatory diseases like rheumatoid arthritis, Sjögren syndrome, dermatomyositis, and systemic lupus erythematosus [7,8,10]. |